Geneva, Oct. 21 -- International Clinical Trials Registry received information related to the study (NCT07210190) titled 'VAMP(TM) ADVANCED and Microneedling for Skin Heath' on Sept. 29.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: None (Open Label).
Primary Sponsor: Erevna Innovations Inc.
Condition:
Aesthetic
Intervention:
Device: Microneedeling with topical application of VAMP™ ADVANCED Topical Multivitamin Serum
Recruitment Status: Recruiting
Phase: Phase 4
Date of First Enrollment: October 1, 2025
Target Sample Size: 30
Countries of Recruitment:
Canada
To know more, visit https://clinicaltrials.gov/study/NCT072101...